Company registration number 08368580 (England and Wales)
RENEVIR LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
RENEVIR LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2
Notes to the financial statements
3 - 4
RENEVIR LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF RENEVIR LIMITED FOR THE YEAR ENDED 31 MARCH 2025
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Renevir Limited for the year ended 31 March 2025 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

This report is made solely to the Board of Directors of Renevir Limited, as a body. Our work has been undertaken solely to prepare for your approval the financial statements of Renevir Limited and state those matters that we have agreed to state to the Board of Directors of Renevir Limited, as a body. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Renevir Limited and its Board of Directors as a body, for our work or for this report.

It is your duty to ensure that Renevir Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Renevir Limited. You consider that Renevir Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Renevir Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Kirk Rice LLP
1 December 2025
The Courtyard
High Street
Ascot
Berkshire
SL5 7HP
RENEVIR LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 2 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
5,186
-
0
Cash at bank and in hand
798,027
799,285
803,213
799,285
Creditors: amounts falling due within one year
4
(9,641)
(14,448)
Net current assets
793,572
784,837
Capital and reserves
Called up share capital
2
2
Profit and loss reserves
793,570
784,835
Total equity
793,572
784,837

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 30 November 2025 and are signed on its behalf by:
Mr A J Scrivener
Director
Company Registration No. 08368580
RENEVIR LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Renevir Limited is a private company limited by shares incorporated in England and Wales. The registered office is River View, Ferry Road, South Stoke, Oxfordshire, RG8 0JP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

RENEVIR LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.4
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
5,186
-
0
4
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
7,803
4,969
Other creditors
1,838
9,479
9,641
14,448
2025-03-312024-04-01falsefalsefalse01 December 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr B ScrivenerMrs C L ScrivenerMr A J Scrivener083685802024-04-012025-03-31083685802025-03-31083685802024-03-3108368580core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3108368580core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3108368580core:CurrentFinancialInstruments2025-03-3108368580core:CurrentFinancialInstruments2024-03-3108368580core:ShareCapital2025-03-3108368580core:ShareCapital2024-03-3108368580core:RetainedEarningsAccumulatedLosses2025-03-3108368580core:RetainedEarningsAccumulatedLosses2024-03-3108368580bus:Director32024-04-012025-03-31083685802023-04-012024-03-3108368580core:WithinOneYear2025-03-3108368580core:WithinOneYear2024-03-3108368580bus:PrivateLimitedCompanyLtd2024-04-012025-03-3108368580bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3108368580bus:FRS1022024-04-012025-03-3108368580bus:AuditExemptWithAccountantsReport2024-04-012025-03-3108368580bus:Director12024-04-012025-03-3108368580bus:Director22024-04-012025-03-3108368580bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP